Purchases and Sales Made in Q3 2023 in Crinetics Pharmaceuticals, Inc. (CRNX)
This table provides information about the institutional ownership of Crinetics Pharmaceuticals, Inc. (CRNX) during Q3 2023. The information is specifically focused on institutions that hold shares of Crinetics Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 09, 2023
Q3 2023
|
Gw&K Investment Management, LLC
Boston, MA |
SELL
|
- |
-103K- 17.55% |
$1.64M - $3.14M
|
483K
$27.1M
|
|
|
Nov 09, 2023
Q3 2023
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-163K- 84.93% |
$2.6M - $4.99M
|
28.9K
$1.62M
|
|
|
Nov 14, 2023
Q3 2023
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-166K- 3.13% |
$2.65M - $5.07M
|
5.13M
$288M
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-235K- 31.47% |
$3.75M - $7.18M
|
511K
$28.7M
|
|
|
Nov 14, 2023
Q3 2023
|
5 Am Venture Management, LLC
San Francisco, CA |
SELL
|
- |
-400K- 46.39% |
$6.39M - $12.2M
|
462K
$25.9M
|
|
|
Nov 14, 2023
Q3 2023
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-475K- 56.21% |
$7.59M - $14.5M
|
370K
$20.7M
|
|
|
Nov 14, 2023
Q3 2023
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-683K- 35.09% |
$10.9M - $20.9M
|
1.26M
$70.9M
|
|
|
Nov 14, 2023
Q3 2023
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-1.05M- 26.7% |
$16.8M - $32.3M
|
2.9M
$162M
|